Karyopharm Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).

CEO

Richard A. Paulson

CEORichard A. Paulson

Employees

442

Employees442

Headquarters

Newton, Massachusetts

HeadquartersNewton, Massachusetts

Founded

2008

Founded2008

Employees

442

Employees442

KPTI Key Statistics

Market cap

386.06M

Market cap386.06M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.93M

Average volume1.93M

High today

$3.54

High today$3.54

Low today

$3.27

Low today$3.27

Open price

$3.38

Open price$3.38

Volume

2.02M

Volume2.02M

52 Week high

$14.73

52 Week high$14.73

52 Week low

$2.45

52 Week low$2.45

Analyst ratings

60%

of 10 ratings

Buy

60%

Hold

40%

Sell

KPTI Earnings

-$0.74

-$0.34

$0.06

$0.46

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

-$0.34 per share

Estimated-$0.34 per share

Actual

Expected Feb 17, Pre-Market

ActualExpected Feb 17, Pre-Market